NFSG
MRNA icon

Newbridge Financial Services Group’s Moderna MRNA Stock Holding History

Newbridge Financial Services Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Sell
200
-2,000
-91% -$103K ﹤0.01% 792
2026
Q1 		$112K Sell
2,200
-5,300
-71% -$247K 0.02% 296
2025
Q4 		$221K Hold
7,500
– – 0.03% 222
2025
Q3 		$194K Buy
7,500
+5,144
+218% +$143K 0.03% 304
2025
Q2 		$65K Hold
2,356
– – 0.01% 457
2025
Q1 		$66.8K Buy
2,356
+1,255
+114% +$44.5K 0.02% 317
2024
Q4 		$45.8K Sell
1,101
-416
-27% -$19.9K 0.01% 425
2024
Q3 		$101K Sell
1,517
-261
-15% -$24K 0.04% 195
2024
Q2 		$211K Buy
1,778
+68
+4% +$8.61K 0.08% 176
2024
Q1 		$182K Sell
1,710
-116
-6% -$11.7K 0.08% 205
2023
Q4 		$182K Buy
1,826
+50
+3% +$4.21K 0.09% 200
2023
Q3 		$183K Buy
1,776
+120
+7% +$13.4K 0.09% 198
2023
Q2 		$201K Sell
1,656
-58
-3% -$7.74K 0.1% 199
2023
Q1 		$263K Hold
1,714
– – 0.14% 149
2022
Q4 		$308K Buy
1,714
+157
+10% +$25.7K 0.18% 123
2022
Q3 		$184K Buy
1,557
+92
+6% +$14K 0.11% 199
2022
Q2 		$209K Buy
1,465
+200
+16% +$28.6K 0.13% 159
2022
Q1 		$218K Buy
1,265
+183
+17% +$30.8K 0.11% 185
2021
Q4 		$275K Buy
1,082
+64
+6% +$18.7K 0.13% 158
2021
Q3 		$392K Buy
1,018
+572
+128% +$211K 0.25% 94
2021
Q2 		$105K Sell
446
-250
-36% -$44.7K 0.06% 275
2021
Q1 		$91K Buy
696
+141
+25% +$20.4K 0.07% 271
2020
Q4 		$58K Sell
555
-449
-45% -$45.4K 0.05% 299
2020
Q3 		$71K Buy
+1,004
New +$70K 0.07% 245

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Newbridge Financial Services Group's MRNA Position: Q2 2026 in Review

Newbridge Financial Services Group reduced its Moderna (MRNA) stake by 91% in Q2 2026, selling an estimated $103K and leaving 200 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #792.

Newbridge Financial Services Group first reported a position in MRNA in Q3 2020 and has held it in 24 quarters since. The position peaked at $392K in Q3 2021. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Newbridge Financial Services Group held 200 shares of Moderna worth $14K as of Q2 2026.
  • Newbridge Financial Services Group sold 2,000 Moderna shares in Q2 2026, an estimated $103K.
  • Moderna made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #792 holding.
  • Newbridge Financial Services Group first reported a position in Moderna in Q3 2020 and has held it in 24 quarters since.
  • Newbridge Financial Services Group's Moderna position peaked at $392K in Q3 2021.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.